Targeted biopsy for breast cancer that has spread to lymph nodes
Part of Cancer, Skin clinical trials.
This study reviews patients with early breast cancer that has spread to a small number of lymph nodes. It looks at how well a special biopsy removes those nodes during surgery, to help guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have early-stage breast cancer (T1-2) that has not spread beyond nearby lymph nodes.
- The cancer has spread to 1 or 2 lymph nodes under the arm, confirmed by biopsy.
- You are having surgery as your first treatment (not chemotherapy before surgery).
- At least three lymph nodes will be removed during the procedure.
- You have not had previous lymph node removal under the same arm.
- Only 1 or 2 lymph nodes show cancer on imaging, not more.
- You have not had large (T3-4) or advanced tumors.
- Any cancer found in the removed nodes must be larger than 0.2 mm (macrometastases).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a more focused surgery approach to remove lymph nodes in the armpit for people with early breast cancer that has been found in 1–2 axillary lymph nodes. It may help guide more precise treatment while checking how well this approach works.
This study tests a way to decide whether women with early breast cancer and one or two affected lymph nodes can safely skip full lymph node removal. It uses a special biopsy to guide surgery and reduce side effects.
This trial is testing a targeted surgical approach to remove only the suspicious lymph nodes under the arm for people with early-stage, hormone receptor positive, HER2 negative breast cancer. The goal is to see if this less extensive surgery is safe and effective when there is limited lymph node involvement.
This trial tests a less extensive armpit surgery after chemotherapy for breast cancer that had spread to lymph nodes. The goal is to see if removing only the sentinel nodes (guided by blue dye) is safe and effective when nodes appear clear after treatment.
This trial studies an additional treatment given after chemotherapy for locally advanced breast cancer that has spread to specific underarm lymph nodes. It may help some people reduce cancer returning, especially when tumors match certain growth and spread features.
This trial studies a treatment plan for early breast cancer that involves at least three suspicious lymph nodes on the ultrasound/imaging. It looks at whether a targeted technique—done before surgery with chemotherapy—can improve or guide care when surgery will remove the lymph nodes.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.